DIETary Intake, Death and Hospitalization in Adult With End-stage Kidney Disease Treated With HemoDialysis (DIET-HD) Study

The DIETary intake, death and hospitalisation in adults with end-stage kidney disease treated with HaemoDialysis (DIET-HD) study is a multinational prospective cohort study designed to evaluate the association between nutrition and dietary patterns and health outcomes in prevalent adult haemodialysis patients in Europe and South America.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diet Habit Behavior Behavior, Animal Chronic Disease Disease Attributes End Stage Renal Disease Feeding Behavior Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Kidney Failure, Chronic Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

End-stage kidney disease
Long-term haemodialysis for at least the previous 90 days
18 years or older
Treating team agrees to the patient's involvement in the study
Participant willing to provide written and informed consent.-

Exclusion criteria

significant neurocognitive disability or medical comorbidity that would preclude them from understanding the dietary questionnaire even if assisted
a life expectancy less than 6 months according to their treating physician
planned kidney transplantation within 6 months of baseline

Treatment and study plan

dietary intake of omega-3 and omega-6 polyunsaturated fatty acids

Other

Primary outcomes

Cardiovascular mortality

Time frame: 12 months since baseline dietary evaluation

Defined as sudden death or death attributed to acute myocardial infarction, pericarditis, atherosclerotic heart disease, cardiomyopathy, cardiac arrhythmia, cardiac arrest, valvular heart disease, pulmonary edema, or congestive cardiac failure

Secondary outcomes

All-cause mortality

Time frame: 12 months since baseline dietary evaluation
Infection-related mortality

Time frame: 12 months since baseline dietary evaluation
All-cause and cardiovascular related hospitalisation

Time frame: 12 months since baseline dietary evaluation

Sponsors and collaborators

Lead sponsor

Giovanni Strippoli

Other

Collaborators

University of Sydney

Registry information

Important dates

Study start: 2014
Primary completion: 2016
Study completion: 2016
First posted: Apr 24, 2017
Registry last updated: Apr 24, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed